Airfinity announces Alexander Karle, former CEO of Evaluate, as newest advisor

Posted on Dec 15, 2023

Alex brings more than 15 years of experience in rapidly growing data and analytics businesses. After heading up strategy and M&A for Thomson Reuters’ Life Sciences business, Alex oversaw the rapid growth at Evaluate, the leader in Life Sciences consensus forecasts.

Alex also acted as a board adviser to Scibite during its successful exit to Elsevier in 2020.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022